
Buffett's senior apprentice
Alphabet Quiet builder$Novo Nordisk AS(NVO.US) Eli Lilly and Novo Nordisk announced an agreement to reduce the price of GLP-1 weight-loss drugs, with both companies setting the price at $245 per month.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
